has been cited by the following article(s):
[1]
|
Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications
Journal of Hematology & Oncology,
2016
DOI:10.1186/s13045-016-0263-4
|
|
|